WHO ICTRP trial
A randomized, open-label, single and multiple ascending dose phase 1 clinical…
KCT0005915 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0005915 |
|---|---|
| Public title | A randomized, open-label, single and multiple ascending dose phase 1 clinical trial to investigate the pharmacokinetic and tolerability of AST-001 administration in healthy subjects |
| Scientific title | A randomized, open-label, single and multiple ascending dose phase 1 clinical trial to investigate the pharmacokinetic and tolerability of AST-001 administration in healthy subjects |
| Primary sponsor | Astrogen |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase1 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the nervous system |
| Interventions | Drug : G1: AST-001 10g PO single dose G2: ASR-001 20g PO single dose G3: AST-001 30g PO single dose and 7-day washout period, after AST-001 15g QD, AST-001 15g BID for 7 days |
| Registration date | Feb 19, 2021 |
| Target size | 24 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: